Publication | Closed Access
Delphinidin Induces Necrosis in Hepatocellular Carcinoma Cells in the Presence of 3-Methyladenine, an Autophagy Inhibitor
56
Citations
30
References
2009
Year
Macroautophagy InhibitorChemoprevention StrategyAutophagy ActivationApoptosisHepatocellular Carcinoma CellsCell DeathPathologyAutophagy InhibitorCell AutophagyDifferent ModesAutophagyHepatotoxicityAnti-cancer AgentLiver PhysiologyDelphinidin Induces NecrosisPharmacologyCell BiologyDrug-induced Liver InjuryTumor MicroenvironmentHepatologyLiver CancerTumor SuppressorMedicineHepatocellular Carcinoma
The present study was performed to determine whether anthocyanins could trigger different modes of cell death in different cancers. It was found that whereas cyanidin-3-rutinoside and delphinidin could induce apoptosis in leukemia cells, they caused growth retardation in hepatocellular carcinoma cells (HCC), which was accompanied with a significant cellular vacuolization. The latter was likely caused by macroautophagy and was completely suppressed by 3-methyladenine, an inhibitor of class III phosphoinositide 3-kinase that is important for autophagy activation, and by bafilomycin A1, which blocks lysosomal degradation. Delphinidin induced significant lipidation of LC3, an indication of macroautophagy, which was also suppressed by 3-methyladenine. Macroautophagy was required for the survival of delphinidin-treated HCC cells as inhibition with 3-methyladenine led to massive necrosis without caspase activation. Thus, anthocyanins could induce different modes of cell death for different cancers. Furthermore, anthocyanins could be used in combination with a macroautophagy inhibitor for treating cancers such as HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1